1.0
Oct 22, 2020
Former employee, more than 1 year
London, England
Recommend
CEO approval
Business outlook
Pros
Internationally recognised, good exposure to business problems faced in pharma
Cons
A company driven purely by profits at the expense of employee experience, health and wellbeing. They have a monopoly on data which they have been exploiting for years, but provide a substandard quality of services.